Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance). (Q36294970)

13 August 2017

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance). (English)

1 reference

13 August 2017

11

1 reference

13 August 2017

10

Elaine Mardis

1 reference

13 August 2017

3

Minetta Liu

1 reference

13 August 2017

5

James N Ingle

1 reference

13 August 2017

Constance T Cirrincione

2

object named as

Constance T Cirrincione

1 reference

13 August 2017

13

Eric Winer

1 reference

13 August 2017

1

Jennifer A Ligibel

1 reference

13 August 2017

7

Silvana Martino

1 reference

13 August 2017

8

William Sikov

1 reference

13 August 2017

14

Clifford A Hudis

1 reference

13 August 2017

Marc Citron

4

1 reference

13 August 2017

William Gradishar

6

1 reference

13 August 2017

Richard Michaelson

9

1 reference

13 August 2017

Matthew Ellis

12

1 reference

13 August 2017

Donald Berry

15

1 reference

13 August 2017

William T Barry

16

1 reference

13 August 2017

language of work or name

English

0 references

publication date

25 June 2015

1 reference

Journal of the National Cancer Institute

13 August 2017

1 reference

13 August 2017

107

1 reference

13 August 2017

9

1 reference

Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Associations of insulin resistance and adiponectin with mortality in women with breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Weight loss in breast cancer patient management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast: findings from a case-series study

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4651106

Undertreatment of obese women receiving breast cancer chemotherapy

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26113580

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26113580

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJV179

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

26113580

1 reference